Corporate Insolvencies in Germany Signal Economic Strain Despite Temporary Decline

In the first quarter of 2026, large company insolvencies in Germany decreased by 35% compared to the previous quarter and by 27% year-on-year, suggesting initial signs of relief. However, the situation remains tense with insolvency numbers still aligning with a five-year average of 67 cases, highlighting ongoing economic challenges. Prof. Dr. Michael Grömling from the Institute of the German Economy describes this as a "stagnation chain" persisting since 2019, where only 14% of companies report improved conditions, while 43% perceive deterioration. Among industrial firms, 42% plan to reduce investments in 2026, potentially undermining future competitiveness due to high energy costs, complex supply chain risks, and bureaucratic burdens.

Amid this difficult economic backdrop, Molecular Health GmbH, a biotech IT firm primarily owned by SAP co-founder Dietmar Hopp’s Dievini-Holding, has filed for insolvency as of June 1, 2026. Financial troubles were triggered by the loss of a major client, forcing the company into self-administration since March. The firm focuses on software for precision and in-silico medicine. Under restructuring, only one of its two business units will continue, and part of the approximately 60 employees will be retained. A new start-up, Lucera, has emerged from Molecular Health’s core business, employing 25 staff members and aiming to maintain continuity through a potential sale to an international investor group. This restructuring reflects wider distress in the medical sector, which is also experiencing significant job cuts and company closures.

Prof. Grömling advises startups and businesses to invest boldly in productivity, customer proximity, and employee training, emphasizing technology adoption and new business models as keys to overcoming stagnation. The decline in insolvencies and asset deals may partly reflect a cautious investor climate, signaling that economic difficulties remain and companies must adapt strategically to survive and grow.